These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 18097856

  • 1. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T, Arnoux S, Kobryn A, Gorski P.
    J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856
    [Abstract] [Full Text] [Related]

  • 2. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers.
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 4. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM, Aoki F, Ward BJ, McGeer A, Angel JB, Stiver G, Gorfinkel I, Shu D, White L, Lasko B, Dzongowski P, Papp K, Alexander M, Boivin G, Fries L.
    Vaccine; 2011 Feb 24; 29(10):1921-8. PubMed ID: 21219987
    [Abstract] [Full Text] [Related]

  • 5. The safety and immunogenicity of influenza vaccine in children with asthma in Mexico.
    Pedroza A, Huerta JG, Garcia Mde L, Rojas A, López-Martínez I, Penagos M, Franco-Paredes C, Deroche C, Mascareñas C.
    Int J Infect Dis; 2009 Jul 24; 13(4):469-75. PubMed ID: 19084453
    [Abstract] [Full Text] [Related]

  • 6. The safety of inactivated influenza vaccine in adults and children with asthma.
    The American Lung Association Asthma Clinical Research Centers.
    N Engl J Med; 2001 Nov 22; 345(21):1529-36. PubMed ID: 11794219
    [Abstract] [Full Text] [Related]

  • 7. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial.
    Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M.
    Arch Intern Med; 1996 Jul 22; 156(14):1546-50. PubMed ID: 8687262
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

  • 9. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.
    Scheifele DW, Duval B, Russell ML, Warrington R, DeSerres G, Skowronski DM, Dionne M, Kellner J, Davies D, MacDonald J.
    Clin Infect Dis; 2003 Apr 01; 36(7):850-7. PubMed ID: 12652385
    [Abstract] [Full Text] [Related]

  • 10. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M.
    J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.
    Langley JM, Halperin SA, McNeil S, Smith B, Jones T, Burt D, Mallett CP, Lowell GH, Fries L.
    Vaccine; 2006 Mar 06; 24(10):1601-8. PubMed ID: 16303215
    [Abstract] [Full Text] [Related]

  • 12. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI, Caprio M, Hendricks-Munoz K.
    Pediatrics; 2007 Sep 06; 120(3):e617-21. PubMed ID: 17766502
    [Abstract] [Full Text] [Related]

  • 13. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.
    Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, Wiselka MJ, Leese J, Ayres J, Campbell JH, Ebden P, Eiser NM, Hutchcroft BJ, Pearson JC, Willey RF, Wolstenholme RJ, Woodhead MA.
    Lancet; 1998 Jan 31; 351(9099):326-31. PubMed ID: 9652613
    [Abstract] [Full Text] [Related]

  • 14. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA, Nauta J, Cramer WC, Gerez L, Palache AM.
    Vaccine; 2005 Jul 08; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.
    Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T, Karvonen A, Smith HM, Dunning A, Razmpour A, Saville MK, Gruber WC, Forrest BD.
    Pediatrics; 2008 Mar 02; 121(3):e568-73. PubMed ID: 18299305
    [Abstract] [Full Text] [Related]

  • 17. [Safety of influenza vaccination in asthmatics].
    Kmiecik T, Sek K, Górski P.
    Pneumonol Alergol Pol; 2006 Mar 02; 74(4):365-71. PubMed ID: 17427144
    [Abstract] [Full Text] [Related]

  • 18. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
    Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, Walker R, Hessel C, Cordova J, Mendelman PM.
    Pediatr Infect Dis J; 2004 Feb 02; 23(2):138-44. PubMed ID: 14872180
    [Abstract] [Full Text] [Related]

  • 19. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM.
    J Infect Dis; 2006 May 01; 193(9):1223-8. PubMed ID: 16586358
    [Abstract] [Full Text] [Related]

  • 20. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.
    Iorio A, Basileo M, Marcucci M, Guercini F, Camilloni B, Paccamiccio E, Vecchioli M, Iorio AM.
    Arch Intern Med; 2010 Apr 12; 170(7):609-16. PubMed ID: 20386004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.